Incidentally, anti-TP53 has been shown to have detection marker potential in HGSOC [81] and preliminary results by our group in a set of 728 sera (123 ovarian cancer cases, 369 healthy controls, 144 benign ovarian disease, 92 surgical controls) showed performance similar to that reported here in breast cancer (unpublished). This evidence concerns the gene TP53 and ovarian cancer.